TipRanks
Advertisement
Advertisement

DE:KK3A Stock Latest News

Cytokinetics price target raised to $113 from $112 at RBC Capital
The FlyCytokinetics price target raised to $113 from $112 at RBC Capital
2d ago
CYTK
Mizuho biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Mizuho biotech analysts hold an analyst/industry conference call
9d ago
BBIO
BIIB
Cytokinetics announces start of ASPEN-HCM
PremiumThe Fly
Cytokinetics announces start of ASPEN-HCM
10d ago
CYTK
Cytokinetics announces results from ACACIA-HCM, MAPLE-HCM
PremiumThe Fly
Cytokinetics announces results from ACACIA-HCM, MAPLE-HCM
1M ago
CYTK
Cytokinetics Reports Positive Phase 3 Aficamten HCM Results
PremiumCompany Announcements
Cytokinetics Reports Positive Phase 3 Aficamten HCM Results
1M ago
8K
CYTK
Morning Movers: PayPal sinks after report says Advent, Stripe lost interest
PremiumThe FlyMorning Movers: PayPal sinks after report says Advent, Stripe lost interest
1M ago
CHA
GAP
Cytokinetics reports ACACIA-HCM trial met both primary endpoints
Premium
The Fly
Cytokinetics reports ACACIA-HCM trial met both primary endpoints
1M ago
CYTK
Cytokinetics Earnings Call Highlights MYQORZO Surge
Premium
Company Announcements
Cytokinetics Earnings Call Highlights MYQORZO Surge
2M ago
CYTK
Hold Rating Reaffirmed as Patent Dispute Adds Risk; $85 Price Target Remains Unchanged
PremiumRatings
Hold Rating Reaffirmed as Patent Dispute Adds Risk; $85 Price Target Remains Unchanged
2M ago
CYTK
Cytokinetics price target raised to $110 from $95 at Barclays
PremiumThe Fly
Cytokinetics price target raised to $110 from $95 at Barclays
2M ago
CYTK
Cytokinetics price target raised to $103 from $97 at JPMorgan
PremiumThe Fly
Cytokinetics price target raised to $103 from $97 at JPMorgan
2M ago
CYTK
Cytokinetics Files Patent Suit to Protect MYQORZO Franchise
PremiumCompany Announcements
Cytokinetics Files Patent Suit to Protect MYQORZO Franchise
2M ago
8K
CYTK
Cytokinetics price target raised to $112 from $106 at Truist
PremiumThe FlyCytokinetics price target raised to $112 from $106 at Truist
2M ago
CYTK
Cytokinetics price target raised to $85 from $83 at BofA
Premium
The Fly
Cytokinetics price target raised to $85 from $83 at BofA
2M ago
CYTK
Cytokinetics price target raised to $112 from $102 at Needham
Premium
The Fly
Cytokinetics price target raised to $112 from $102 at Needham
2M ago
CYTK
Cytokinetics price target lowered to $112 from $117 at RBC Capital
PremiumThe Fly
Cytokinetics price target lowered to $112 from $117 at RBC Capital
2M ago
CYTK
Cytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target
PremiumRatings
Cytokinetics: Strong MYQORZO Launch and Upcoming Catalysts Support Buy Rating and Unchanged $140 Price Target
2M ago
CYTK
Cytokinetics price target raised to $110 from $105 at Citizens
PremiumThe Fly
Cytokinetics price target raised to $110 from $105 at Citizens
2M ago
CYTK
Cytokinetics reports Q2 EPS ($1.50), consensus ($1.60)
PremiumThe Fly
Cytokinetics reports Q2 EPS ($1.50), consensus ($1.60)
2M ago
CYTK
Cytokinetics (CYTK) Q2 Earnings Cheat Sheet
PremiumPre-EarningsCytokinetics (CYTK) Q2 Earnings Cheat Sheet
2M ago
CYTK
Cytokinetics announces MHRA authorization for Myqorzo
Premium
The Fly
Cytokinetics announces MHRA authorization for Myqorzo
2M ago
CYTK
Cytokinetics price target lowered to $117 from $119 at RBC Capital
Premium
The Fly
Cytokinetics price target lowered to $117 from $119 at RBC Capital
3M ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >